Publication | Closed Access

Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients

TransplantationHepatologyKidney TransplantViral HepatitisMedicineTransplantation MedicineHepatitis BHepatitisAntiviral TherapyRenal Transplant RecipientsAcute Liver FailureFulminant Hepatic FailureHepatitis B VirusLiver TransplantationPharmacologyNephrology